Impact of concomitant atrial fibrillation on the prognosis of Takotsubo cardiomyopathy

Abstract

Rates of in-hospital events and short- as well as long-term mortality were significantly higher in TTC patients suffering from atrial fibrillation compared with patients without atrial fibrillation.

Parametry echokardiograficzne wpływające na rokowanie pacjentów z kardiomiopatią takotsubo

“…Złożony punkt końcowy w postaci powikłań zakrzepowo-zatorowych, zagrażających życiu arytmii, śmiertelności z jakiejkolwiek przyczyny, rehospitalizacji z powodu niewydolności serca, udaru mózgu oraz nawrotu TTC wystąpił częściej u pacjentów z migotaniem i z EF nie wyższą niż 35% [23]. Mniejsza, ale nieistotna statystycznie śmiertelność w obserwacji długoterminowej była obserwowana w grupie pacjentów, którzy otrzymali beta-adrenolityk przy wypisie ze szpitala, w porównaniu z pacjentami, u których nie zalecono beta-adrenolityku.…”

Protective effect of acquired long QT syndrome in Takotsubo syndrome

“…TTS often affects post‐menopausal women and is often provoked by preceding emotional or physical stress . TTS may be associated with some critical complications such as heart failure, arrhythmias, thromboembolic events, recurrence of TTS, LV outflow obstruction, mitral valve regurgitation and cardiac rupture . Clinical variables that predict long‐term mortality and recurrence are not completely understood.…”

“…6 TTS may be associated with some critical complications such as heart failure, arrhythmias, thromboembolic events, recurrence of TTS, LV outflow obstruction, mitral valve regurgitation and cardiac rupture. 6,[10][11][12] Clinical variables that predict long-term mortality and recurrence are not completely understood. The rate of recurrence has been reported in up to 20%.…”

The presence of atrial fibrillation in Takotsubo cardiomyopathy is predictive of mortality: Systematic review and meta‐analysis

“…Atrial fibrillation (AF) is a common arrhythmia in TTC patients with a prevalence of 18%–25% (El‐Battrawy, Lang, Ansari, Behnes, et al, ; Stiermaier, Santoro, et al, ). Some studies report that concomitant AF is a predictor of short‐term and long‐term mortality in TTC patients (El‐Battrawy, Lang, Ansari, Behnes, et al, ; Stiermaier, Santoro, et al, ).…”

“…Atrial fibrillation (AF) is a common arrhythmia in TTC patients with a prevalence of 18%–25% (El‐Battrawy, Lang, Ansari, Behnes, et al, ; Stiermaier, Santoro, et al, ). Some studies report that concomitant AF is a predictor of short‐term and long‐term mortality in TTC patients (El‐Battrawy, Lang, Ansari, Behnes, et al, ; Stiermaier, Santoro, et al, ). AF is also commonly known as a poor outcome predictor among patients with ACS (Angeli et al, ; Lin et al, ; Maagh et al, ; Poci, Hartford, Karlsson, Edvardsson, & Caidahl, ; Podolecki et al, ; Stamboul et al, ; Viliani et al, ).…”